Clearing of GB3 From Endothelial Vessels of Ocular Conjunctiva in Fabry Patients Treated with Agalsidase-Alfa

Update Item Information
Identifier 20060228_nanos_posters_002.pdf
Title Clearing of GB3 From Endothelial Vessels of Ocular Conjunctiva in Fabry Patients Treated with Agalsidase-Alfa
Creator R. Ebner; P. Rozenfeld; O. Croxatto; C. Fossati
Affiliation Houston, TX
Subject Fabry Disease; Lysosomal Disease; Agalidase-alpha; Gb3; Alpha-galactosidase
Description Fabry's disease is an X-linked inborn metabolic error caused by a deficiency of lysosomal ?- galactosidase A. Globotriaosylceramide (Gb3) accumulates in lysosomes of various cells. At the moment, enzyme replacement therapy is the only available specific treatment for Fabry patients. Enzyme infusions reduced the content of plasma, urine sediment and tissue Gb3. The aim of this work is to evaluate the clearance of Gb3 in cells from the conjunctiva in Fabry patients treated with agalsidase alfa.
Date 2006-02-28
Language eng
Format application/pdf
Type Text
Source 2006 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2006: Poster Presentations
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s65x5g93
Setname ehsl_novel_nam
ID 181057
Reference URL https://collections.lib.utah.edu/ark:/87278/s65x5g93
Back to Search Results